The Interplay Between Adipokines and Body Composition in Obesity and Metabolic Diseases
Open Access
- 27 January 2025
- journal article
- review article
- Published by Springer Nature in Cureus
- Vol. 17 (1) , e78050
Abstract
The worldwide health system faces challenges from obesity and related metabolic disorders because they exhibit both rising rates of occurrence and intricate pathophysiological mechanisms. This work examines how adipokines interact with body composition during obesity to control important metabolic functions. Bioactive molecules produced by adipose tissue function as adipokines which regulate essential biological pathways that control inflammation response and insulin sensitivity alongside energy balance management and immune system operation. The disruption of adipokine secretion and function leads directly to metabolic disorders which include insulin resistance and persistent inflammation characteristic of obesity-related conditions. This article investigates the therapeutic possibilities of adipokine pathway manipulation through new pharmacological approaches and lifestyle changes alongside personalized medicine developments. Researchers analyze adipokines as important biomarkers for patient disease classification and their application in creating individualized treatment plans. The review highlights existing research deficiencies and obstacles that stand in the way of applying adipokine discoveries to clinical settings. This article integrates existing research to show how adipokine regulation helps prevent obesity-related metabolic issues and suggests directions for future studies to enhance treatment results.Keywords
This publication has 50 references indexed in Scilit:
- Janus kinase/signal transducers and activator of transcription (JAK/STAT) and its role in Lung inflammatory diseaseChemico-Biological Interactions, 2023
- White adipose tissue dysfunction in obesity and agingBiochemical Pharmacology, 2021
- Role of Inflammatory Cytokines, Growth Factors and Adipokines in Adipogenesis and Insulin ResistanceInflammation, 2021
- Leptin as a key regulator of the adipose organReviews in Endocrine and Metabolic Disorders, 2021
- Chemerin in inflammatory diseasesClinica Chimica Acta, 2021
- Recent advances and future avenues in understanding the role of adipose tissue cross talk in mediating skeletal muscle mass and function with ageingGeroScience, 2021
- Resistin: Potential biomarker and therapeutic target in atherosclerosisClinica Chimica Acta, 2021
- Adipokines as novel biomarkers of cardio-metabolic disordersClinica Chimica Acta, 2020
- The many secret lives of adipocytes: implications for diabetesDiabetologia, 2018
- Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical ImplicationsHepatology, 2010